[1]
Fonseca, M.S. et al. 2023. Use of pioglitazone in diabetic patients with Alzheimer’s disease-related cognitive impairment. Research, Society and Development. 12, 5 (Apr. 2023), e5212541438. DOI:https://doi.org/10.33448/rsd-v12i5.41438.